+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver Cancer Drugs Market Research Reports

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 645 Pages
  • Global
From
Liver Cancer Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Liver Cancer Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • January 2020
  • 2099 Pages
  • Global
From
Hepatocellular Carcinoma: Competitive Landscape to 2026 - Product Thumbnail Image

Hepatocellular Carcinoma: Competitive Landscape to 2026

  • Report
  • November 2018
  • 50 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 1275 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1561 Pages
  • Global
From
Liver Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Companies in China

  • Report
  • September 2023
  • 69 Pages
  • China
From
Liver Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Markets in China

  • Report
  • September 2023
  • 239 Pages
  • China
From
Nexavar - API Insight, 2022 - Product Thumbnail Image

Nexavar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Gemzar - API Insight, 2022 - Product Thumbnail Image

Gemzar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Nexavar- Drug Insight, 2019 - Product Thumbnail Image

Nexavar- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Opdivo- Drug Insight, 2019 - Product Thumbnail Image

Opdivo- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Gemzar- Drug Insight, 2019 - Product Thumbnail Image

Gemzar- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Lenvima- Drug Insight, 2019 - Product Thumbnail Image

Lenvima- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

The Liver Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat liver cancer. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells. Immunotherapy is a type of drug that works by stimulating the body's own immune system to fight cancer. The Liver Cancer Drugs market is highly competitive, with many companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly developing new drugs and treatments to improve the quality of life for those affected by liver cancer. Show Less Read more